Steven Cohen Soma Logic, Inc. Transaction History

Point72 Asset Management, L.P.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$1.76 - $2.83 $7.16 Million - $11.5 Million	-4,070,049 Reduced 94.29%	246,700 $624,000
Q3 2023 Nov 14, 2023	SELL	$1.99 - $2.45 $1.17 Million - $1.44 Million	-589,741 Reduced 12.02%	4,316,749 $10.3 Million
Q2 2023 Aug 14, 2023	BUY	$2.1 - $3.36 $95,396 - $152,634	45,427 Added 0.93%	4,906,490 $11.3 Million
Q1 2023 May 15, 2023	BUY	$2.13 - $3.6 $3.07 Million - $5.19 Million	1,442,766 Added 42.21%	4,861,063 $12.4 Million
Q4 2022 Feb 14, 2023	BUY	$2.05 - $3.47 $1.71 Million - $2.9 Million	836,567 Added 32.4%	3,418,297 $8.58 Million
Q3 2022 Nov 14, 2022	BUY	$0.63 - $5.47 $548,782 - $4.76 Million	871,083 Added 50.92%	2,581,730 $7.49 Million
Q2 2022 Aug 15, 2022	SELL	$4.27 - $8.26 $2.42 Million - $4.68 Million	-566,254 Reduced 24.87%	1,710,647 $7.73 Million
Q1 2022 May 16, 2022	SELL	$7.07 - $11.62 $10.2 Million - $16.8 Million	-1,443,765 Reduced 38.8%	2,276,901 $18.3 Million
Q4 2021 Feb 14, 2022	BUY	$10.49 - $14.28 $25.6 Million - $34.8 Million	2,438,734 Added 190.24%	3,720,666 $43.3 Million
Q3 2021 Nov 15, 2021	BUY	$9.94 - $12.77 $12.7 Million - $16.4 Million	1,281,932 New	1,281,932 $15.9 Million

7.48M

Ticker SLGC
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 183,452,992
Description
SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex prot...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.